Page 15

- Homoeopathy: inaccuracies, misunderstandings and half-truths in allopathic doses.

- Hormone-related malignant tumors.

- Host-tumor antagonism. I. Evidence for the existence of tumor immunity.

- Host-tumor antagonism. III. Prolonged survival of certain patients with cancer; fortuitous occurrence or immunity mechanism?

- Host-tumor antagonism. IV. Immunologic possibilities inherent in some of the theories on the nature of cancer.

- Host-tumor antagonism. 23. The hereditary aspects of cancer.

- HOST-TUMOR ANTAGONISM. 32. THE EPIDEMIOLOGY OF CANCER.

- Host-tumor antagonism. X. Radiation; a double-edged sword.

- Host-tumor antagonism. XI. Recapitulation of various aspects: practical applications of this knowledge to the care of patients.

- Host-tumor antagonism. XIX. Cancer and dysfunction of the liver.

- Host-tumor antagonism. XXIV. The latent period in the formation of cancer: the "cancer-age" myth.

- Host-tumor antagonism. XXXV. Some important aspects of cancer.

- Hot stuff: thermal ablation.

- Human liver catalase activity as a prognostic aid in advanced cancer.

- Human multidrug transporter ABCG2, a target for sensitizing drug resistance in cancer chemotherapy. Human ABCG2, a member of the ATP-binding cassette transporter superfamily which transports a wide variety of substrates, is highly expressed in placental...

- Human reduced folate carrier: translation of basic biology to cancer etiology and therapy. This review attempts to provide a comprehensive overview of the biology of the physiologically and pharmacologically important transport system termed the...

- Hydrogen peroxide yields in x-irradiated aqueous solutions; a sensitive method based on hydrazide chemiluminescence.

- Hydroxyurea (NSC-32065) intermittent therapy in malignant diseases.

- HYPERCALCEMIA OF MALIGNANCY.

- Hyperthermia and the therapy of malignant tumors.